Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A pro-inflammatory signature mediates FGF2-induced angiogenesis.
Andrés G, Leali D, Mitola S, Coltrini D, Camozzi M, Corsini M, Belleri M, Hirsch E, Schwendener RA, Christofori G, Alcamì A, Presta M. Andrés G, et al. Among authors: camozzi m. J Cell Mol Med. 2009 Aug;13(8B):2083-2108. doi: 10.1111/j.1582-4934.2008.00415.x. J Cell Mol Med. 2009. PMID: 18624773 Free PMC article.
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Presta M, Oreste P, Zoppetti G, Belleri M, Tanghetti E, Leali D, Urbinati C, Bugatti A, Ronca R, Nicoli S, Moroni E, Stabile H, Camozzi M, Hernandez GA, Mitola S, Dell'Era P, Rusnati M, Ribatti D. Presta M, et al. Among authors: camozzi m. Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):71-6. doi: 10.1161/01.ATV.0000148863.24445.b4. Epub 2004 Oct 28. Arterioscler Thromb Vasc Biol. 2005. PMID: 15514208
Heparin derivatives as angiogenesis inhibitors.
Presta M, Leali D, Stabile H, Ronca R, Camozzi M, Coco L, Moroni E, Liekens S, Rusnati M. Presta M, et al. Among authors: camozzi m. Curr Pharm Des. 2003;9(7):553-66. doi: 10.2174/1381612033391379. Curr Pharm Des. 2003. PMID: 12570803 Review.
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib.
Joensuu H, Blay JY, Comandone A, Martin-Broto J, Fumagalli E, Grignani G, Del Muro XG, Adenis A, Valverde C, Pousa AL, Bouché O, Italiano A, Bauer S, Barone C, Weiss C, Crippa S, Camozzi M, Castellana R, Le Cesne A. Joensuu H, et al. Among authors: camozzi m. Br J Cancer. 2017 Oct 24;117(9):1278-1285. doi: 10.1038/bjc.2017.290. Epub 2017 Aug 29. Br J Cancer. 2017. PMID: 28850565 Free PMC article. Clinical Trial.
25 results